McLennan, Hanna J. https://orcid.org/0000-0002-2058-2488
Heinrich, Shauna L. https://orcid.org/0000-0001-7586-1030
Inge, Megan P. https://orcid.org/0009-0006-3001-1650
Wallace, Samuel J. https://orcid.org/0000-0002-8535-0928
Blanch, Adam J. https://orcid.org/0000-0001-6565-2438
Hails, Llewelyn https://orcid.org/0009-0005-4603-9466
O’Connor, John P. https://orcid.org/0009-0001-2161-0145
Waite, Michael B. https://orcid.org/0009-0000-7926-0769
McIlfatrick, Stephen
Nottle, Mark B. https://orcid.org/0000-0001-7625-5542
Dunning, Kylie R. https://orcid.org/0000-0002-0462-6479
Gardner, David K. https://orcid.org/0000-0003-3138-8274
Thompson, Jeremy G. https://orcid.org/0000-0003-4941-7731
Love, Allison K. https://orcid.org/0000-0001-9191-5625
Article History
Received: 4 December 2023
Accepted: 21 December 2023
First Online: 18 January 2024
Declarations
:
: Discarded cryopreserved human oocytes used for the pilot study were collected at Flinders Fertility with Ethics Approval from the University of Adelaide Human Ethics Committee (H-2023-082).
: The authors consent for publication of this article.
: Fertilis Pty Ltd has registered a provisional patent in Australia and has filed a PCT patent application for microICSI. It has been developed with the intention of being sold as a product. The microICSI logo is a registered trademark. H. J. M., S. L. H., M. P. I., S. J. W., A. J. B., L. H., J. P. O., M. B. W., J. G. T., and A. K. L. were all employees of Fertilis at the time this study was conducted. D. K. G. and J. G. T. are shareholders of Fertilis; J.G.T. is a director of Fertilis. S. M., M. B. N., and K. R. D. declare no competing interests.